Dow Up0.76% Nasdaq Up0.69%

Valeant Pharmaceuticals International, Inc. (VRX)

129.13 Up 1.11(0.87%) 4:01PM EDT
Cash FlowGet Cash Flow for:
View: Annual Data | Quarterly DataAll numbers in thousands
Period EndingDec 31, 2013Dec 31, 2012Dec 31, 2011
Net Income (866,142) (116,025) 159,559  
Operating Activities, Cash Flows Provided By or Used In
Depreciation2,105,267  1,022,624  639,706  
Adjustments To Net Income178,650  3,257  (21,673)
Changes In Accounts Receivables(261,380)(219,431)(164,581)
Changes In Liabilities(76,548)(8,370)42,067  
Changes In Inventories(122,701)(80,304)(11,521)
Changes In Other Operating Activities82,338  54,827  (3,084)
Total Cash Flow From Operating Activities 1,041,957   656,578   640,473  
Investing Activities, Cash Flows Provided By or Used In
Capital Expenditures(115,319)(107,638)(58,515)
Investments17,020  617,574  5,552  
Other Cash flows from Investing Activities(5,282,087)(3,475,657)(2,755,545)
Total Cash Flows From Investing Activities (5,380,386) (2,965,721) (2,808,508)
Financing Activities, Cash Flows Provided By or Used In
Dividends Paid(2,101) -   -  
Sale Purchase of Stock2,261,822  (257,698)(650,003)
Net Borrowings2,067,410  3,470,677  2,770,687  
Other Cash Flows from Financing Activities(195,565)(134,999)(158,381)
Total Cash Flows From Financing Activities 4,027,752   3,057,368   1,948,165  
Effect Of Exchange Rate Changes(5,074)3,755  (10,288)
Change In Cash and Cash Equivalents (315,751) 751,980   (230,158)

Sign Up for a Free Trial to EDGAR Online Premium!
Get the critical business and financial information you need for more than 15,000 U.S. public companies.
Sign Up Now - Learn More

Currency in USD.